Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study

Iain B. McInnes, Philip J. Mease, Alan Kivitz, Peter Nash, Proton Rahman, Jürgen Rech, Philip G. Conaghan, Bruce Kirkham, Sandra Navarra, Ashwini D Belsare, E.M. Delicha, Luminita Pricop